期刊文献+

LHRH-PE40与正常肝组织和肝癌细胞表面LHRH受体结合特性的比较研究 被引量:3

Comparison between the binding ability of Luteinizing hormone releasing hormone-pseudomonas aeruginesa exotoxin 40 (LHRH-PE40) to human liver cancer cell line and to normal human liver tissues
下载PDF
导出
摘要 目的 探讨重组促性腺激素释放激素 绿脓杆菌外毒素 4 0 (LHRH PE4 0 )与正常肝脏组织和肝癌细胞表面受体结合特性的差异。方法 用放射性配基结合分析的方法测定亲和力和受体容量。结果 LHRH PE4 0与肝癌细胞HEPG细胞的亲和力Kd为 (0 .4 3± 0 .12 )nmol·L-1,受体容量Bmax为 (0 .37± 0 .15 )nmol·mg-1,与正常肝脏组织未见结合。结论 重组毒素LHRH PE4 0和肝癌细胞HEPG的表面受体有较强的结合 ,而和正常肝脏组织无特异性结合。 Objective To evaluate the binding ability of Luteinizing hormone releasing hormone pseudomonas aeruginesa exotoxin 40 (LHRH PE40) to the LHRH receptors on human liver cancer cell line HEPG and to normal human liver tissues. Methods The radioligand binding assay of receptors was used to calculate the K d and Bmax. Results LHRH PE40 could bind to HEPG cell line with high affinity ( K d=0.43?nmol·L -1 ±0.12?nmol·L -1 , Bmax=0.37?nmol·mg -1 ±0.15?nmol·mg -1 ); There were no bindings of LHRH PE40 was found to normal human liver tissues. Conclusion LHRH PE40 has a high binding ability to the LHRH receptors on human liver cancer cell line HEPG, but it can't bind to normal human liver tissues.
出处 《西安交通大学学报(医学版)》 CAS CSCD 北大核心 2003年第3期193-195,共3页 Journal of Xi’an Jiaotong University(Medical Sciences)
基金 国家重点科技攻关计划专题项目 (96 90 1 0 5 10 1)
  • 相关文献

参考文献3

  • 1赵刚,龚守良,岳瑛,朱平.人类促性腺激素释放激素受体在垂体外正常组织和癌组织的分布[J].吉林大学学报(医学版),2002,28(4):445-447. 被引量:20
  • 2Pedroza E, Leek R, Klenk N, et al. Studies on the iodination of LHRH and the biological and immunological activities of the products [J]. Life Sci, 1980, 26(6):1309- 1313.
  • 3Meng RQ, Zhu P, Yao XY, et al. Construction and high level expression of recombinant toxin LRH-PE40 and it's specific cytotoxic activity [ J ]. Ann Anthol Univ Agri Anim Sci PLA, 1995:11 - 17.

二级参考文献14

  • 1Kakar SS, Grizzle WE, Neill JD. The nucleotide sequences of human GnRH receptors in breast and ovarin tumors are identical with that found in pituitary[J]. Mol Cell Endocrinol, 1994, 106:145-149.
  • 2Imai A, Ohno T, Iida K, et al. Gonadotropin-releasing hormone receptor in gynecologic tumors[J]. Cancer, 1994, 74(9):2555-2561.
  • 3Kismanovic LZ, Stojilkovic SS, Mertz LM, et al. Expression of gonadotropin-releasing hormone receptors and autocrine regulation of neuropeptide release in immortalized hypothalamic neurons[J]. Proc Natl Acad Sci USA, 1993, 90:3908-3912.
  • 4Kakar SS, Jennes L. Expression of gonadotropin-releasing hormone and gonadotropin-releasing hormone receptor mRNAs in various non-reproductive human tissues[J]. Cancer lett, 1995, 98:57-62.
  • 5Pati D, Habibi HR. Inhibition of human hepatocarcinoma cell proliferation by mammalian and fish gonadotropin-releasing hormones[J]. Endocrinology, 1995, 136(1):75-84.
  • 6Qayum A, Gullick W, Clayton RC, et al. The effects of gonadotrophin releasing hormone analogues in prostate cancer are mediated through specific tumour receptors[J]. Br J Cancer, 1990, 62:96-99.
  • 7Yano T ,Korkut E, Pinski J, et al. Inhibition of growth of MCF-7 MIII human breast carcinoma in nude mice by treatment with agonists or antagonists of LH-RH[J]. Breast Cancer Res Treat, 1992, 21:35-45.
  • 8Emons G, Schally AV. The use of luteinizing hormone releasing hormone agonists and antagonists in gynaecological cancers[J]. Hum Reprod, 1994,9:1364-1379.
  • 9Srkalovic G, Schally AV, Wittliff JL, et al. Presence and characteristic of receptors for [D-Trp6] luteinizing hormone releasing hormone and epidermal growth factor in human ovarian cancer[J]. Int J Oncol, 1998, 12:489-498.
  • 10Yano T, Pinski J, Radulovic S , et al. Inhibition of human epithelial ovarian cancer cell growth in vitro by agonistic and antagonistic analogues of luteinizing hormone-releasing hormone[J]. Proc Natl Acad Sci USA, 1994,91:1701-1705.

共引文献19

同被引文献36

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部